WeDoctor Postpones Hong Kong IPO to 2021, Eyeing USD 10 Bn Valuation
COVID-19 and China
WeDoctor's public launch be affected by Luckin's fraud? Image credit: PVG/Caixing Global

WeDoctor plans to go public on the Hong Kong Stock Exchange at a valuation of USD 10 billion at the end of 2020 or the beginning of 2021, according to people familiar with the matter.

Earlier this year, rumor had it that the Internet-based healthcare platform would submit its prospectus during the third quarter of 2020, at an estimated valuation of USD 5.5 billion for fundraising of USD 700 – 900 million.

The plan was postponed partly because Credit Suisse may not become the co-sponsor for WeDoctor’s Hong Kong IPO after Luckin Coffee's financial fraud earlier this year.

As early as May 2018, WeDoctor closed a pre-IPO strategic fundraising for USD 500 million, which remains the largest pre-IPO deal in the Chinese telehealthcare industry. The company would consider an IPO from a long-term perspective and the market climate would not be impacted significantly, according to Mr. Chen Hong, the Chief Strategy Officer of WeDoctor.

As one of the pilots in Chinese telehealthcare, WeDoctor has established a closed business circuit, connecting Internet hospitals, general practices, healthcare malls, insurance and a cloud platform.

Latest Updates:

See Also

Communicate Directly with the Author!

Ask the author questions about the copied text

Research Reports
Editor's Picks